American Oncology Network, Inc. (AONC)
OTCMKTS: AONC · Delayed Price · USD
1.360
0.00 (0.00%)
Jul 19, 2024, 3:53 PM EDT - Market open
Company Description
American Oncology Network, Inc., through its subsidiaries, provides oncology services in the United States.
The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with complete, accurate and timely pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services including nutrition guidance.
The company was incorporated in 2017 and is based in Fort Myers, Florida.
American Oncology Network, Inc.
| Country | United States |
| Founded | 2018 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 1,525 |
| CEO | Todd Schonherz |
Contact Details
Address: 14543 Global Pkwy #110 Fort Myers, Florida 33913 United States | |
| Phone | 833-886-1725 |
| Website | aoncology.com |
Stock Details
| Ticker Symbol | AONC |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001839998 |
| CUSIP Number | 028719102 |
| ISIN Number | US0287191029 |
| SIC Code | 8000 |
Key Executives
| Name | Position |
|---|---|
| Todd Schonherz | Chief Executive Officer and Director |
| Dr. Stephen Divers M.D. | Chief Medical Officer, VC of Board of Managers and Chairman of Advisory Board Executive Committee |
| David H. Gould CPA | Chief Financial Officer |
| Mark Moch | Chief Information Officer |
| Kristin Matisziw | Chief Compliance and Risk Officer |
| Erica Mallon | General Counsel |
| Caroline Hewitt | Vice President of Marketing |
| Bridget Russo | Vice President of Human Resources |
| James Gilmore Pharm.D. | Chief Pharmacy and Clinical Services Officer |
| Shelly Glenn | Chief Growth and Relationship Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 3, 2024 | 424B3 | Prospectus |
| Jun 3, 2024 | 8-K | Current Report |
| May 31, 2024 | 25 | Filing |
| May 21, 2024 | 424B3 | Prospectus |
| May 21, 2024 | 8-K | Current Report |
| May 16, 2024 | 424B3 | Prospectus |
| May 15, 2024 | 10-Q | Quarterly Report |
| May 15, 2024 | 8-K | Current Report |
| May 6, 2024 | 424B3 | Prospectus |
| May 3, 2024 | EFFECT | Notice of Effectiveness |